SHL’s Smart Heart
SHL Telemedicine Ltd., a provider and developer of advanced personal telemedicine solutions, announced that the SEC declared effective the Company’s registration statement of its securities in connection with a NASDAQ Listing of its American Depositary Shares (“ADRs”), each representing one ordinary share of the Company. The ADRs are expected to commence trading on The NASDAQ Capital Market (the “Nasdaq”), on April 3 2023 under the ticker symbol “SHLT”, in parallel to its ordinary shares continuing to be listed on the Swiss Stock Exchange.
Founded in 1987, SHL Telemedicine is engaged in developing and marketing personal telemedicine systems and the provision of medical call center services, with a focus on cardiovascular and related diseases, to end users and to the healthcare community. SHL Telemedicine offers its services and personal telemedicine devices to subscribers utilizing telephonic and Internet communication technology.
For example, SHL’s SmartHeart is an FDA cleared hospital-grade 12-lead ECG device, fast, user-friendly, reliable. SmartHeart can be applied by a physician or the patient to perform a full 12-lead ECG. The SHL telemedicine centers professional medical staff are available for you 24/7, will review the ECGs and provide you findings.
Will you offer us a hand? Every gift, regardless of size, fuels our future.
Your critical contribution enables us to maintain our independence from shareholders or wealthy owners, allowing us to keep up reporting without bias. It means we can continue to make Jewish Business News available to everyone.
You can support us for as little as $1 via PayPal at [email protected].
Thank you.
SmartHeartPro data is stored in the cloud. It is secured and HIPAA compliant, so you know your patients’ privacy meets rigorous security standards.
“This is a significant milestone for SHL Telemedicine,” said Yariv Alroy Co-chairman of SHL Telemedicine, “SHL is well positioned to continue realizing its vision of being a leader in the telemedicine field. The listing for trading on one of the world’s leading stock exchanges will increase our access to both retail and institutional investors and is expected to further accelerate our business operations and create value for the Company and its shareholders.”
Bank of New York Mellon (“BNY Mellon”) has been appointed as the depositary bank. The ADRs are priced in USD and provide the same rights in dividends and voting powers as the ordinary shares of SHL. Each ADR represents one ordinary SHL share, subject to the enforcement procedures as per the deposit agreement between SHL, BNY Mellon and the owners of ADRs. The ADRs will be based on the currently issued ordinary shares of SHL and no new share will be issued in connection with the listing of the ADRs.
SuperCom a provider of secured solutions for the e-Government, IoT and Cybersecurity sectors, has entered into a securities purchase agreement with a single institutional investor to purchase approximately $2.4 million worth of its ordinary shares (or pre-funded warrants in lieu thereof) in a registered direct offering (the “Offering”) and warrants to purchase ordinary shares in a concurrent private placement. The combined effective purchase price for one ordinary share (or pre-funded warrant in lieu thereof) and a warrant to purchase one ordinary share will be $1.60.
Founded in 1988, SuperCom offers advanced, secure mobile payments ranging from mobile wallet to mobile POS, using a set of components and platforms to enable secure mobile payments and financial services. SuperCom is a global provider of a unique all-in-one field-proven RFID & mobile PureSecurity advanced solutions suite, accompanied by advanced complementary services for various industries, including healthcare and homecare, security and safety, community public safety, law enforcement, electronic monitoring, livestock monitoring, and building and access automation.
Under the terms of the securities purchase agreement, SuperCom has agreed to sell 1,517,615 ordinary shares (or pre-funded warrants in lieu thereof). In a private placement, which will be consummated concurrently with the Offering, SuperCom has also agreed to issue warrants to purchase up to an aggregate of 1,517,615 ordinary shares. The warrants will be immediately exercisable, will expire five years from the date of issuance, and will have an exercise price of $1.66 per ordinary share.
Maxim Group LLC is acting as the sole placement agent in connection with the Offering.
The Offering is expected to close on or about March 31, 2023, subject to the satisfaction of customary closing conditions.
SuperCom has also agreed that certain existing warrants to purchase up to an aggregate of 564,869 ordinary shares of the Company that were issued to such institutional investor on July 27, 2022, at an exercise price of $3.20 per ordinary share, will be amended effective upon the closing of the Offering so that the amended warrants will have an exercise price of $1.66.
“This is a significant milestone for SHL Telemedicine,” said Yariv Alroy Co-chairman of SHL Telemedicine, “SHL is well positioned to continue realizing its vision of being a leader in the telemedicine field. The listing for trading on one of the world’s leading stock exchanges will increase our access to both retail and institutional investors and is expected to further accelerate our business operations and create value for the Company and its shareholders.”
